Orthofix Medical Q2 Sales USD 210.9 Million Vs. IBES Estimate USD 209.3 Million
OFIX•Orthofix Medical Q2 sales and margins
Aug. 5 (Reuters) - Orthofix Medical Q2 adjusted EBITDA was USD 20.1 million vs. the IBES estimate of USD 22.2 million.
- Q2 adjusted gross margin: 71.7%
- Q2 gross margin: 71%
